From: KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
Outcome and variables | Univariate | Multivariate | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P* | |
Age (yrs) | ||||
≤ 59 | ||||
> 59 | 1.3 (1.0–1.8) | 0.09 | 1.4 (1.0–1.9) | 0.06 |
FIGO Stage | ||||
III | ||||
IV | 1.1 (0.7–1.8) | 0.7 | – | – |
Residual tumor | ||||
≤ 1 cm | ||||
> 1 cm | 1.1 (0.8–1.6) | 0.5 | – | – |
KFL7 | ||||
Low expression | ||||
High expression | 1.6 (1.0–2.4) | 0.037 | 1.5 (1.0–2.3) | 0.03 |